Ethan Creed is a biochemist focused on advancing gene editing technologies to create safe, precise, and accessible treatments for catastrophic diseases. He earned his bachelor's in Biochemistry from The University of Texas at Austin, where he first discovered his passion for research through the Freshman Research Initiative. There, he developed low-cost diagnostic tools to identify carriers of sickle cell traitAs an undergraduate researcher in Dr. Andrew Ellington’s lab, Ethan engineered transcription-factor based biosensors , integrating experimental biology with machine learning to accelerate protein design. These experiences deepened his interest in synthetic biology, computational modeling, and the potential of protein engineering to solve complex biological problems.
Creed's journey with St. Jude began as a Pediatric Oncology Education (POE) intern in the summers of 2023 and 2024, where he trained in the Weiss lab under Dr. Senthil Bhoopalan. His work contributed to modeling Diamond-Blackfan anemia and identifying potential small moelcule therapies. Now as a student in the Biomedical Sciences PhD program, Creed is eager to develop next-generation genome editing tools by combining rational design, machine learning, and experimental validation. He was drawn to St. Jude for its unparalleled mentorship, cutting-edge infrastructure, and shared commitment to scientific discovery that changes lives.
Hometown: Austin, TX
Education:
2025 - BS, Biochemistry (Minor in Social and Behavioral Sciences) - University of Texas at Austin